Dr. Paik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Brigham & Women's Hospital
75 Francis St, Renal Div Mrb-4
Boston, MA 02115Phone+1 617-732-6383- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2007 - 2011
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2004 - 2007
- Icahn School of Medicine at Mount SinaiClass of 2004
Certifications & Licensure
- MA State Medical License 2007 - 2025
- NY State Medical License 2005 - 2007
Publications & Presentations
PubMed
- Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD.Arnaud D Kaze, Elisabetta Patorno, Julie M Paik> ;Current Opinion in Nephrology and Hypertension. 2023 Jul 1
- 5 citationsSafety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study.Edouard L Fu, Elvira D'Andrea, Deborah J Wexler, Elisabetta Patorno, Julie M Paik> ;Clinical Journal of the American Society of Nephrology. 2023 Feb 24
- 15 citationsComparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels.Elvira D'Andrea, Deborah J Wexler, Seoyoung C Kim, Julie M Paik, Ethan Alt, Elisabetta Patorno> ;JAMA Internal Medicine. 2023 Mar 1
- Join now to see all
Press Mentions
- Empagliflozin May Reduce Stone RiskNovember 5th, 2022
- SGLT2 Inhibitor Use Rising in Patients with DKDAugust 23rd, 2021
- SGLT2 Inhibitors Reduce Kidney Stone Risk in Type 2 DiabetesFebruary 9th, 2024
- Join now to see all
Hospital Affiliations
- Boston Medical CenterBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: